Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

MR Guided Focused Ultrasound (FUS) for the Treatment of Trigeminal Neuralgia

NCT: NCT04579692 · ACTIVE_NOT_RECRUITING

NCT IDNCT04579692
StatusACTIVE_NOT_RECRUITING
Start Date2021-08-16
Completion2026-12-31
SponsorUniversity of Maryland, Baltimore (OTHER)
First posted
Last updated

Brief Summary

The purpose of this study is to assess the safety and effectiveness of MRI-guided focused ultrasound (MRgFUS) for treating Trigeminal Neuralgia. Trigeminal Neuralgia (pain) is a type of pain involving the face that can be disabling to those it affects.

Frequently Asked Questions

What is MR Guided Focused Ultrasound (FUS) for the Treatment of Trigeminal Neuralgia?

MR Guided Focused Ultrasound (FUS) for the Treatment of Trigeminal Neuralgia is a clinical trial registered under NCT04579692. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT04579692?

The current status of NCT04579692 (MR Guided Focused Ultrasound (FUS) for the Treatment of Trigeminal Neuralgia) is: ACTIVE_NOT_RECRUITING.

When did MR Guided Focused Ultrasound (FUS) for the Treatment of Trigeminal Neuralgia start?

MR Guided Focused Ultrasound (FUS) for the Treatment of Trigeminal Neuralgia started on 2021-08-16.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.